294 related articles for article (PubMed ID: 18056431)
21. MiR-34, SIRT1 and p53: the feedback loop.
Yamakuchi M; Lowenstein CJ
Cell Cycle; 2009 Mar; 8(5):712-5. PubMed ID: 19221490
[TBL] [Abstract][Full Text] [Related]
22. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
[TBL] [Abstract][Full Text] [Related]
23. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
24. Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
Hargraves KG; He L; Firestone GL
Mol Carcinog; 2016 May; 55(5):486-98. PubMed ID: 25789847
[TBL] [Abstract][Full Text] [Related]
25. Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma.
Metheetrairut C; Chotigavanich C; Amornpichetkul K; Keskool P; Ongard S; Metheetrairut C
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):521-533. PubMed ID: 30515607
[TBL] [Abstract][Full Text] [Related]
26. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
[TBL] [Abstract][Full Text] [Related]
27. Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype.
Gueta K; Molotski N; Gerchikov N; Mor E; Savion S; Fein A; Toder V; Shomron N; Torchinsky A
BMC Dev Biol; 2010 Feb; 10():20. PubMed ID: 20170545
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of miR-34a-5p antagonizes AFB1-induced genotoxicity in F344 rat liver.
Liu C; Yu H; Zhang Y; Li D; Xing X; Chen L; Zeng X; Xu D; Fan Q; Xiao Y; Chen W; Wang Q
Toxicon; 2015 Nov; 106():46-56. PubMed ID: 26385312
[TBL] [Abstract][Full Text] [Related]
29. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
30. CRKL oncogene is downregulated by p53 through miR-200s.
Tamura M; Sasaki Y; Kobashi K; Takeda K; Nakagaki T; Idogawa M; Tokino T
Cancer Sci; 2015 Aug; 106(8):1033-40. PubMed ID: 26079153
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs, wild-type and mutant p53: more questions than answers.
Jones M; Lal A
RNA Biol; 2012 Jun; 9(6):781-91. PubMed ID: 22664917
[TBL] [Abstract][Full Text] [Related]
32. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the p53/microRNA Network in Cancer.
Kaller M; Hünten S; Siemens H; Hermeking H
Adv Exp Med Biol; 2022; 1385():187-228. PubMed ID: 36352215
[TBL] [Abstract][Full Text] [Related]
34. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
35. Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.
Li XL; Jones MF; Subramanian M; Lal A
FEBS Lett; 2014 Aug; 588(16):2610-5. PubMed ID: 24726728
[TBL] [Abstract][Full Text] [Related]
36. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
[TBL] [Abstract][Full Text] [Related]
37. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
38. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.
Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M
Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294
[TBL] [Abstract][Full Text] [Related]
39. miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
Neault M; Mallette FA; Richard S
Cell Rep; 2016 Mar; 14(8):1966-78. PubMed ID: 26904954
[TBL] [Abstract][Full Text] [Related]
40. Alternative mechanisms of miR-34a regulation in cancer.
Slabáková E; Culig Z; Remšík J; Souček K
Cell Death Dis; 2017 Oct; 8(10):e3100. PubMed ID: 29022903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
